GlassScriptPhysician profile
Jeanette L Lain
NPI 1871516351
$8,283.26
in general payments reported to CMS, 2019-2025
45 companies · $2,402 in 2025
The $2,402 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $722 · 2022: $1,007 · 2023: $2,086 · 2024: $2,066 · 2025: $2,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,264 · Education: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,264.35 |
| Education | $289.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $746.40 | 2022-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $709.55 | 2021-2025 | Xtandi, Myrbetriq |
| Myriad Genetic Laboratories, INC. | $582.08 | 2021-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $543.28 | 2021-2024 | Aveed, Xiaflex, Edex |
| Pfizer INC. | $441.54 | 2022-2025 | |
| Procept Biorobotics Corporation | $409.72 | 2024-2025 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $396.09 | 2021-2025 | Provenge |
| Merck Sharp & Dohme LLC | $382.75 | 2022-2025 | Lynparza, Keytruda |
| Abbvie INC. | $319.71 | 2022-2025 | |
| Coloplast Corp | $312.44 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $289.12 | 2023-2025 | |
| Amgen INC. | $281.80 | 2021-2023 | Prolia |
| Sumitomo Pharma America, INC. | $272.77 | 2023-2025 | Orgovyx, Gemtesa |
| Endo USA, INC. | $272.28 | 2024-2025 | Xiaflex, Aveed |
| Novartis Pharmaceuticals Corporation | $260.03 | 2022-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $203.44 | 2024-2025 | Adstiladrin |
| Teleflex LLC | $141.98 | 2023-2025 | Barrigel, Urolift |
| Tempus Ai, INC | $129.90 | 2025 | Xt Cdx |
| Ibsa Pharma INC. | $125.00 | 2023 | Tirosint |
| Pharming Healthcare, INC. | $124.99 | 2024 | Ruconest |
| Urogen Pharma, INC. | $102.40 | 2023-2025 | Jelmyto |
| Astrazeneca Pharmaceuticals LP | $96.23 | 2022-2025 | Bevespi Aerosphere |
| Blue Earth Diagnostics | $94.86 | 2023 | |
| Johnson & Johnson Health Care Systems INC. | $94.55 | 2022 | |
| Sun Pharmaceutical Industries INC. | $93.65 | 2021-2025 | Yonsa |
| Janssen Scientific Affairs, LLC | $79.00 | 2021-2025 | Erleada, Pipeline |
| Verity Pharmaceuticals INC. | $74.56 | 2022-2024 | Trelstar |
| Antares Pharma, INC. | $73.36 | 2022 | |
| Healthtronics Stone Solutions, LLC | $67.06 | 2021 | |
| Myovant Sciences INC. | $59.60 | 2021-2022 | |
| 180 Medical, INC. | $56.57 | 2022 | |
| Tolmar, INC. | $52.78 | 2023-2024 | |
| Accord Healthcare, INC. | $48.50 | 2023-2024 | |
| Boston Scientific Corporation | $45.55 | 2021 | |
| Medtronic, INC. | $45.43 | 2023-2024 | Interstim |
| Calyxo, INC. | $38.34 | 2025 | Cvac Aspiration System |
| Axonics, INC. | $36.22 | 2022-2023 | Axonics |
| Tolmar Pharmaceuticals, INC. | $35.50 | 2022 | |
| Bioprotect Medical, INC. | $34.93 | 2024-2025 | Bioprotect Balloon Implant System |
| Foundation Medicine, INC. | $26.15 | 2023 | |
| Hollister Incorporated | $19.33 | 2023 | Infyna Chic, Onli, Vapro Pocket |
| Telix Pharmaceuticals | $18.54 | 2024 | Illuccix |
| Olympus America INC. | $18.02 | 2023 | Itind System |
| Clarus Therapeutics INC. | $15.22 | 2021 | |
| Laborie Medical Technologies Corp. | $12.04 | 2025 | Aquarius Lt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanette Lain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.